Capitalization |
9 Months Ended |
|---|---|
Dec. 31, 2025 | |
| Equity [Abstract] | |
| Capitalization | Capitalization On April 17, 2025, our board of directors (the "Board") approved recommitting our existing share repurchase program so that $250,000 was available. The share repurchase program has no expiration date. For the nine months ended December 31, 2025, we repurchased $186,813 of our common stock, or approximately 1,146 shares, of which $117,660, or approximately 658 shares, was made in connection with the Notes. The shares repurchased during the period were funded primarily from the net proceeds received from the issuance of the Notes, as well as from existing cash and cash equivalents balances and cash flows provided by our operations. The remaining amount available under the share repurchase program as of December 31, 2025 was $63,187. Subsequent Event On January 14, 2026, the Board approved recommitting our existing share repurchase program so that $250,000 was available. The share repurchase program has no expiration date. |